carbodiimides has been researched along with caffeic acid in 2 studies
Studies (carbodiimides) | Trials (carbodiimides) | Recent Studies (post-2010) (carbodiimides) | Studies (caffeic acid) | Trials (caffeic acid) | Recent Studies (post-2010) (caffeic acid) |
---|---|---|---|---|---|
1,534 | 1 | 361 | 2,074 | 15 | 1,187 |
Protein | Taxonomy | carbodiimides (IC50) | caffeic acid (IC50) |
---|---|---|---|
RNA polymerase beta subunit (EC 2.7.7.6), partial | Escherichia coli | 23.7759 | |
Lipoxygenase | Solanum tuberosum (potato) | 3.5 | |
Interstitial collagenase | Homo sapiens (human) | 0.2389 | |
Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 3 | |
Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | 3 | |
72 kDa type IV collagenase | Homo sapiens (human) | 0.0243 | |
Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 8.5 | |
Matrix metalloproteinase-9 | Homo sapiens (human) | 0.0156 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 3.06 | |
Dipeptidyl peptidase 4 | Homo sapiens (human) | 3.37 | |
Type-1 angiotensin II receptor | Homo sapiens (human) | 0.1246 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3 | |
Integrase | Human immunodeficiency virus 1 | 2.8 | |
large T antigen | Betapolyomavirus macacae | 7.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aytekin, AO; Kida, K; Morimura, S | 1 |
Bolley, J; Haddad, O; Lalatonne, Y; Letourneur, D; Motte, L; Pérard-Viret, J; Soussan, M | 1 |
2 other study(ies) available for carbodiimides and caffeic acid
Article | Year |
---|---|
Synthesis of chitosan-caffeic acid derivatives and evaluation of their antioxidant activities.
Topics: Caffeic Acids; Carbodiimides; Chitosan; Free Radical Scavengers; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Molecular Weight; Polymerization; Temperature | 2011 |
Optimized multimodal nanoplatforms for targeting α(v)β3 integrins.
Topics: Caffeic Acids; Carbodiimides; Contrast Media; Ferric Compounds; Humans; Hydrogen-Ion Concentration; Integrin alphaVbeta3; Magnetic Resonance Imaging; Magnetics; Metal Nanoparticles; Oligopeptides; Polyethylene Glycols; Protein Binding; Rhodamine 123; Surface Plasmon Resonance; Surface Properties | 2013 |